| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2020 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| 0 | 4 | Q4 2019 | 0.0% |
| CIGNA CORP | 1 | Q4 2018 | 24.7% |
| IQVIA HOLDINGS INC | 1 | Q4 2018 | 19.8% |
| CENTENE CORP | 1 | Q4 2018 | 10.2% |
| MICRON TECHNOLOGY INC | 1 | Q4 2018 | 9.2% |
| F5 NETWORKS INC | 1 | Q4 2018 | 8.9% |
| ADOBE INC | 1 | Q4 2018 | 6.9% |
| CADENCE DESIGN SYS INC | 1 | Q4 2018 | 5.2% |
| NEKTAR THERAPEUTICS | 1 | Q4 2018 | 4.1% |
| CHARLES RIVER LABORATORIES | 1 | Q4 2018 | 3.7% |
View Kresge Foundation's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-02-28 |
| 13F-HR | 2019-12-04 |
| 13F-HR | 2019-08-29 |
| 13F-HR | 2019-05-16 |
| 13F-HR | 2019-02-19 |
View Kresge Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.